1,606
Views
5
CrossRef citations to date
0
Altmetric
Coronavirus – Research Article

Factors influencing COVID-19 vaccine decision-making among hesitant adopters in the United States

, , , & ORCID Icon
Article: 2114701 | Received 26 May 2022, Accepted 16 Aug 2022, Published online: 07 Sep 2022

References

  • Centers for Disease Control and Prevention. COVID data tracker [accessed 2022 Mar 31]. https://covid.cdc.gov/covid-data-tracker/ .
  • Coronavirus Resource Center. Johns Hopkins University of Medicine; [accessed 2022 May 19]. https://coronavirus.jhu.edu/ .
  • Centers for Disease Control and Prevention. Science brief: COVID-19 vaccines and vaccination; Published 2021 [accessed 2022 Mar 31]. https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/fully-vaccinated-people.html.
  • Balasuriya L, Santilli A, Morone J, Ainooson J, Roy B, Njoku A, Mendiola-Iparraguirre A, O’Connor Duffany K, Macklin B, Higginbottom J. COVID-19 vaccine acceptance and access among Black and Latinx communities. JAMA Netw Open. 2021;4(10):1. doi:10.1001/jamanetworkopen.2021.28575.
  • Williams AM, Clayton HB, Singleton JA. Racial and ethnic disparities in COVID-19 vaccination coverage: the contribution of socioeconomic and demographic factors. Am J Prev Med. 2022;62(4):473–10. doi:10.1016/j.amepre.2021.10.008.
  • Nguyen KH, Anneser E, Toppo A, Allen JD, Scott Parott J, Corlin L. Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States. Vaccine. 2022;40(1):107–113. doi:10.1016/j.vaccine.2021.11.040.
  • Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. doi:10.1016/j.eclinm.2020.100495.
  • Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, Vangala S, Kapteyn A. National trends in the US public’s likelihood of getting a COVID-19 vaccine—April 1 to December 8, 2020. Jama. 2021;325(4):396–398. doi:10.1001/jama.2020.26419.
  • Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–277. doi:10.1007/s10900-020-00958-x.
  • Shekhar R, Sheikh A, Upadhyay S, Singh M, Kottewar S, Mir H, Barrett E, Pal S. COVID-19 vaccine acceptance among health care workers in the United States. Vaccines. 2021;9(2):119. doi:10.3390/vaccines9020119.
  • Willis DE, Andersen JA, Bryant-Moore K, Selig JP, Long CR, Felix HC, Curran GM, McElfish PA. COVID-19 vaccine hesitancy: race/ethnicity, trust, and fear. Clin Transl Sci. 2021;14(6):2200–2207. doi:10.1111/cts.13077.
  • World Health Organization. Ten threats to global health in 2019. 2019 [accessed 2022 May 26]. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
  • Daly M, Jones A, Robinson E. Public trust and willingness to vaccinate against COVID-19 in the US from October 14, 2020 to March 29, 2021. J Am Med Assoc. 2021;325(23):2397. doi:10.1001/jama.2021.8246.
  • MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164. doi:10.1016/j.vaccine.2015.04.036.
  • Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J Vaccine hesitancy: an overview. Hum Vaccines Immunother. 2013;9:1763–1773. doi:10.4161/hv.24657.
  • Kirzinger A, Sparks G, Brodie M. KFF COVID-19 vaccine monitor: in their own words, six months later. Kaiser Family Foundation; 2021 [accessed 2022 Mar 31]. https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-in-their-own-words-six-months-later/ .
  • Enkel S, Attwell K, Snelling T, Christian H. ‘Hesitant compliers’: qualitative analysis of concerned fully-vaccinating parents. Vaccine. 2018;36(44):6459–6463. doi:10.1016/j.vaccine.2017.09.088.
  • Willis DE, Selig JP, Andersen JA, Hall S, Hallgren E, Williams M, Bryant-Moore K, McElfish PA. Hesitant but vaccinated: assessing COVID-19 vaccine hesitancy among the recently vaccinated. J Behav Med. 2022. doi:10.1007/s10865-021-00270-6.
  • Purvis RS, Hallgren E, Moore RA, Willis DE, Hall S, Gurel-Headley M, McElfish PA. Trusted sources of COVID-19 vaccine information among hesitant adopters in the United States. Vaccines (Basel). 2021;9(12):1418. doi:10.3390/vaccines9121418.
  • Hallgren E, Moore R, Purvis RS, Hall S, Willis DE, Reece S, CarlLee S, Gurel-Headley M, McElfish PA. Facilitators to vaccination among hesitant adopters. Hum Vaccin Immunother. 2021;17(12):5168–5175. doi:10.1080/21645515.2021.2010427.
  • Moore R, Purvis RS, Hallgren E, et al. Motivations to vaccinate among hesitant adopters of the COVID-19 vaccine. J Community Health. 2022;47(2):237–245. doi:10.1007/s10900-021-01037-5.
  • Lloyd R. People are getting COVID shots despite hesitation. Scientific American; 2022 [accessed 2022 Mar 10]. https://www.scientificamerican.com/article/people-are-getting-covid-shots-despite-hesitation/ .
  • World Health Organization. Report of the SAGE Working Group on Vaccine Hesitancy. 2014 [accessed 2022 Aug 23]. https://www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf.
  • Carson SL, Casillas A, Castellon-Lopez Y, Mansfield LN, Morris D, Barron J, Ntekume E, Landovitz R, Vassar SD, Norris KC. COVID-19 vaccine decision-making factors in racial and ethnic minority communities in Los Angeles, California. JAMA Netw Open. 2021;4(9):e2127582. doi:10.1001/jamanetworkopen.2021.27582.
  • Kulkarni S, Harvey B, Prybylski D, Jalloh MF. Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014-2017: use and comparability of the Vaccine Hesitancy Matrix. Hum Vaccin Immunother. 2021;17(7):2001–2007. doi:10.1080/21645515.2020.1859319.
  • Fridman A, Gershon R, Gneezy A. COVID-19 and vaccine hesitancy: a longitudinal study. PloS One. 2021;16(4):e0250123. doi:10.1371/journal.pone.0250123.
  • Bokemper SE, Huber GA, Gerber AS, James EK, Omer SB. Timing of COVID-19 vaccine approval and endorsement by public figures. Vaccine. 2021;39(5):825–829. doi:10.1016/j.vaccine.2020.12.048.
  • Latkin C, Dayton LA, Yi G, Konstantopoulos A, Park J, Maulsby C, Kong X. COVID-19 vaccine intentions in the United States, a social-ecological framework. Vaccine. 2021;39(16):2288–2294. doi:10.1016/j.vaccine.2021.02.058.
  • Ledford CJW, Cafferty LA, Moore JX, et al. The dynamics of trust and communication in COVID-19 vaccine decision making: a qualitative inquiry. J Health Commun. 2022;27(1):17–26. doi:10.1080/10810730.2022.2028943.
  • Morales GI, Lee S, Bradford A, De Camp A, Tandoc EC. Exploring vaccine hesitancy determinants during the COVID-19 pandemic: an in-depth interview study. SSM Qual Res Health. 2022;2:100045. doi:10.1016/j.ssmqr.2022.100045.
  • Berry SD, Johnson KS, Myles L, Herndon L, Montoya A, Fashaw S, Gifford D. Lessons learned from frontline skilled nursing facility staff regarding COVID -19 vaccine hesitancy. J Am Geriatr Soc. 2021;69(5):1140–1146. doi:10.1111/jgs.17136.
  • Kricorian K, Civen R, Equils O. COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety. Hum Vaccin Immunother. 2022;18(1):1950504. doi:10.1080/21645515.2021.1950504.
  • Colorafi KJ, Evans B. Qualitative descriptive methods in health science research. Herd. 2016;9(4):16–25. doi:10.1177/1937586715614171.
  • 4media group. Media group: intelligence, content, communications, digital; [accessed 2022]. https://www.4media-group.com/ .
  • Quinn SC, Jamison AM, An J, Hancock GR, Freimuth VS. Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: results of a national survey of White and African American adults. Vaccine. 2019;37(9):1168–1173. doi:10.1016/j.vaccine.2019.01.033.
  • Quinn SC, Jamison A, Freimuth VS, An J, Hancock GR, Musa D. Exploring racial influences on flu vaccine attitudes and behavior: results of a national survey of White and African American adults. Vaccine. 2017;35(8):1167–1174. doi:10.1016/j.vaccine.2016.12.046.
  • Quint JJ, Van Dyke ME, Maeda H, Worthington JK, Dela Cruz MR, Kaholokula JK, Matagi CE, Pirkle CM, Roberson EK, Sentell T. Disaggregating data to measure racial disparities in COVID-19 outcomes and guide community response — Hawaii, March 1, 2020–February 28, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(37):1267–1273. doi:10.15585/mmwr.mm7037a1.
  • Chang R, Penaia C, Thomas K. Count Native Hawaiian and Pacific Islanders in COVID-19 data-it’s an OMB Mandate. Health Affairs Blog; 2020 [accessed 2022 May 26]. https://www.healthaffairs.org/do/10.1377/forefront.20200825.671245/full/ .
  • Guest G, Bunce A, Johnson L. How many interviews are enough?: an experiment with data saturation and variability. Field Methods. 2006;18(1):59–82. doi:10.1177/1525822X05279903.
  • Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PloS One. 2020;15(5):e0232076. doi:10.1371/journal.pone.0232076.
  • Archibald MM, Ambagtsheer RC, Casey MG, Lawless M. Using zoom videoconferencing for qualitative data collection: perceptions and experiences of researchers and participants. Int J Qual Method. 2019;18:1–8. doi:10.1177/1609406919874596.
  • Zoom Video Communications. Security guide white paper. Zoom Video Communications Inc; 2021 [accessed 2022 May 26].https://explore.zoom.us/docs/doc/Zoom-Security-White-Paper.pdf.
  • MAXQDA, software for qualitative data analysis [computer program]. Berlin (Germany): VERBI Software; 1989-2015.
  • Webb C. Analysing qualitative data: computerized and other approaches. J Adv Nurs. 1999;29(2):323–330. doi:10.1046/j.1365-2648.1999.00892.x.
  • Rubin HJ, Rubin IS. Qualitative interviewing: the art of hearing data. 2nd ed. Thousand Oaks (CA): Sage Publications; 2005.
  • Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288. doi:10.1177/1049732305276687.
  • Burla L, Knierim B, Barth J, Liewald K, Duetz M, Abel T. From text to codings: intercoder reliability assessment in qualitative content analysis. Nurs Res. 2008;57(2):113–117. doi:10.1097/01.NNR.0000313482.33917.7d.
  • MacQueen KM, McLellan E, Kay K, Milstein B Codebook development for team-based qualitative analysis. Cult Anthropol Method. 1998;10:31–36.
  • Rolfe G. Validity, trustworthiness and rigour: quality and the idea of qualitative research. J Adv Nurs. 2006;53(3):304–310. doi:10.1111/j.1365-2648.2006.03727.x.
  • Hennink M, Hutter I, Bailey A. Qualitative research methods. London, Los Angeles, New Delhi, Singapore, Washington DC: Sage Publications; 2011.
  • Speziale HJ, Carpenter DR. Qualitative research in nursing. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2007.
  • Creswell JW, Poth CN. Qualitative inquiry and research design: choosing among five approaches. 4th ed. Thousand Oaks (CA): Sage Publications; 2016.
  • Anderson C. Presenting and evaluating qualitative research. Am J Pharm Educ. 2010;74(8):141. doi:10.5688/aj7408141.
  • Ponterotto J, Grieger I. Effectively communicating qualitative research. Couns Psychol. 2007;35(3):404–430. doi:10.1177/0011000006287443.
  • Sanders CB, Cuneo CJ. Social reliability in qualitative team research. Sociology. 2010;44(2):325–343. doi:10.1177/0038038509357194.
  • Willis DE, Andersen JA, Montgomery BEE, Selig JP, Shah SK, Zaller N, Bryant-Moore K, Scott AJ, Williams M, McElfish PA. COVID-19 vaccine hesitancy and experiences of discrimination among Black adults. J Racial Ethn Health Disparities. 2022:1–10. doi:10.1007/s40615-022-01290-x.
  • Boyle J, Brassell T, Dayton J. Who do Americans trust for COVID-19 news and information? ICF Int ; 2020 [accessed 2022 May 26].https://www.icf.com/insights/health/covid-19-public-health-findings-mitigation.
  • Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, Zhang B, Kriner DL. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Network Open. 2020;3(10):e2025594. doi:10.1001/jamanetworkopen.2020.25594.
  • Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38(42):6500–6507. doi:10.1016/j.vaccine.2020.08.043.